COMy Virtual 2020 | Managing myeloma during COVID-19: German perspective
Katja Weisel
Katja Weisel, MD, of the University Medical Center Hamburg-Eppendorf, Hamburg, Germany, shares her experience of the impact of COVID-19 in the management of multiple myeloma (MM) patients in Germany. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
Related videos
1:08 Next steps in multiple myeloma
Sagar Lonial
4:44 Management of relapsed/refractory myeloma
Maria-Victoria Mateos
1:25 Rise of antibody-based treatments in myeloma
Sagar Lonial
5:52 BCMA targeting agents in myeloma
Nikhil C. Munshi
2:10 Why should smoldering myeloma be treated early?
Maria-Victoria Mateos
